Pharmacotherapy follow-up in the prevention of cardiovascular disease


Autoria(s): Abreu, Marta; Castel-Branco, Margarida; Caramona, M. Margarida; Monteiro, P.; Fernandez-Llimos, Fernando; Figueiredo, Isabel V.
Data(s)

15/04/2015

15/04/2015

2013

13/12/2014

Resumo

Cardiovascular diseases are the leading cause of death in Portugal, alike what is verified in the remaining western countries. There are factors that increase the risk of its occurrence, that do not usually emerge isolated, tending to group in the individual. This coexistence results in a combined effect which is larger than the one expected from the sum of its individual effects. The global cardiovascular risk is defined as the percentage change of developing a cardiovascular event over a given period of time (generally 10 years). The purpose of global cardiovascular risk assessment is to identify the individuals who should be counseled and receive treatment to prevent a cardiovascular disease, as well as to establish the therapeutics aggressiveness level.

Identificador

Abreu, Marta; Castel-Branco, Margarida; Caramona, M. Margarida; Monteiro, P; Fernandez-Llimos, Fernando; Figueiredo, Isabel V. Pharmacotherapy follow-up in the prevention of cardiovascular disease. In FIP World Congress "Towards a Future Vision for Complex Patients". Dublin 2013, 31 Aug-5 Sept. Dublin:FIP, 2013

http://hdl.handle.net/10451/17932

Idioma(s)

eng

Relação

http://www.fip.org/abstracts?page=abstracts&action=item&item=8649

Direitos

restrictedAccess

Tipo

conferenceObject